Heparin derivatives in acute coronary syndromes

Thesis

Cover

Stellingen behorend bij het proefschrift

Titlepage

Contents

1 General Introduction

2 Low-molecular weight heparins in venous and arterial thrombotic disease

3 The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of lowmolecular weight heparin in the initial treatment of acute coronary syndromes

4 Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular weight heparin

5 Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: Results from the TIMI 11B and ESSENCE studies

6 Effects of clopidogrel on the rebound hypercoagulable state in acute coronary syndrome patients after heparin discontinuation

7 Ability of recombinant factor Vlla to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers

8 Recombinant factor Vlla reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers

9 Summary and Discussion

10 Samenvatting

11 Dankwoord

12 Curriculum Vitae

Cover